MAIN ALAN J
Insider CIK 1227372 · LXRX EVP, Pharmaceutical Research
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2025-02-28 | 2025-03-03 | 32,904 | — | $0 | 32,903 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2025-02-28 | 2025-03-03 | 25,667 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2025-02-28 | 2025-03-03 | 68,243 | — | $0 | 136,487 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2025-02-28 | 2025-03-03 | 25,667 | — | $0 | 281,391 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2025-02-28 | 2025-03-03 | 32,904 | — | $0 | 314,295 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2025-02-28 | 2025-03-03 | 68,243 | — | $0 | 382,538 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2025-02-28 | 2025-03-03 | 43,434 | $0.67 | $29.1K | 339,104 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2025-02-13 | 2025-02-18 | 502,060 | — | $0 | 502,060 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2025-02-13 | 2025-02-18 | 753,090 | — | $0 | 753,090 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2024-02-28 | 2024-02-29 | 8,977 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2024-02-28 | 2024-02-29 | 25,666 | — | $0 | 25,667 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2024-02-28 | 2024-02-29 | 32,903 | — | $0 | 65,807 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2024-02-28 | 2024-02-29 | 25,666 | — | $0 | 247,229 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2024-02-28 | 2024-02-29 | 32,903 | — | $0 | 280,132 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2024-02-28 | 2024-02-29 | 24,408 | $2.62 | $63.9K | 255,724 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2024-02-28 | 2024-02-29 | 8,977 | — | $0 | 221,563 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2024-02-08 | 2024-02-12 | 204,730 | — | $0 | 204,730 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2024-02-08 | 2024-02-12 | 204,730 | — | $0 | 204,730 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2023-02-28 | 2023-03-01 | 25,667 | — | $0 | 51,333 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2023-02-28 | 2023-03-01 | 8,976 | — | $0 | 8,977 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2023-02-28 | 2023-03-01 | 23,300 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2023-02-28 | 2023-03-01 | 25,667 | — | $0 | 233,532 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2023-02-28 | 2023-03-01 | 23,300 | — | $0 | 198,889 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2023-02-28 | 2023-03-01 | 8,976 | — | $0 | 207,865 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2023-02-28 | 2023-03-01 | 20,946 | $2.17 | $45.5K | 212,586 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2023-02-09 | 2023-02-13 | 98,710 | — | $0 | 98,710 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2023-02-09 | 2023-02-13 | 296,130 | — | $0 | 296,130 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2022-02-28 | 2022-02-28 | 8,977 | — | $0 | 17,953 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2022-02-28 | 2022-02-28 | 22,373 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2022-02-28 | 2022-02-28 | 23,300 | — | $0 | 23,300 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2022-02-28 | 2022-02-28 | 19,756 | $2.85 | $56.3K | 175,589 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2022-02-28 | 2022-02-28 | 22,373 | — | $0 | 163,068 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2022-02-28 | 2022-02-28 | 23,300 | — | $0 | 186,368 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2022-02-28 | 2022-02-28 | 8,977 | — | $0 | 195,345 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2022-02-10 | 2022-02-14 | 77,000 | — | $0 | 77,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2022-02-10 | 2022-02-14 | 230,990 | — | $0 | 230,990 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-02-28 | 2021-03-02 | 2,497 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-02-28 | 2021-03-02 | 8,297 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-02-28 | 2021-03-02 | 23,300 | — | $0 | 46,600 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-02-28 | 2021-03-02 | 22,374 | — | $0 | 22,373 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-02-28 | 2021-03-02 | 23,300 | — | $0 | 161,108 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-02-28 | 2021-03-02 | 2,497 | — | $0 | 107,137 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-02-28 | 2021-03-02 | 8,297 | — | $0 | 115,434 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-02-28 | 2021-03-02 | 22,374 | — | $0 | 137,808 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2021-02-28 | 2021-03-02 | 20,413 | $7.19 | $146.8K | 140,695 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2021-02-11 | 2021-02-16 | 80,780 | — | $0 | 80,780 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2021-02-11 | 2021-02-16 | 26,930 | — | $0 | 26,930 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2020-04-22 | 2020-04-24 | 6,813 | $1.96 | $13.4K | 104,640 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award | 2020-04-22 | 2020-04-24 | 19,893 | — | $0 | 111,453 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 22,373 | — | $0 | 44,747 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 4,085 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 2,498 | — | $0 | 2,497 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 8,296 | — | $0 | 8,297 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 22,373 | — | $0 | 104,319 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2020-02-28 | 2020-03-03 | 12,759 | $2.77 | $35.3K | 91,560 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 4,085 | — | $0 | 71,152 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 2,498 | — | $0 | 73,650 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 8,296 | — | $0 | 81,946 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2020-02-06 | 2020-02-10 | 209,700 | — | $0 | 209,700 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2020-02-06 | 2020-02-10 | 69,900 | — | $0 | 69,900 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2019-02-28 | 2019-03-01 | 5,271 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2019-02-28 | 2019-03-01 | 8,297 | — | $0 | 16,593 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2019-02-28 | 2019-03-01 | 4,085 | — | $0 | 4,085 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2019-02-28 | 2019-03-01 | 2,498 | — | $0 | 4,995 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2019-02-28 | 2019-03-01 | 2,498 | — | $0 | 65,655 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2019-02-28 | 2019-03-01 | 5,271 | — | $0 | 59,072 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2019-02-28 | 2019-03-01 | 8,297 | — | $0 | 73,952 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2019-02-28 | 2019-03-01 | 6,885 | $5.51 | $37.9K | 67,067 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2019-02-28 | 2019-03-01 | 4,085 | — | $0 | 63,157 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2019-02-07 | 2019-02-08 | 124,640 | — | $0 | 124,640 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2019-02-07 | 2019-02-08 | 67,120 | — | $0 | 67,120 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2018-02-28 | 2018-03-02 | 2,497 | — | $0 | 7,493 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2018-02-28 | 2018-03-02 | 4,085 | — | $0 | 8,170 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2018-02-28 | 2018-03-02 | 5,272 | — | $0 | 5,271 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2018-02-28 | 2018-03-02 | 2,679 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2018-02-28 | 2018-03-02 | 4,962 | $8.53 | $42.3K | 53,801 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2018-02-28 | 2018-03-02 | 2,497 | — | $0 | 58,763 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2018-02-28 | 2018-03-02 | 4,085 | — | $0 | 56,266 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2018-02-28 | 2018-03-02 | 2,679 | — | $0 | 46,909 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2018-02-28 | 2018-03-02 | 5,272 | — | $0 | 52,181 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2018-02-08 | 2018-02-12 | 24,890 | — | $0 | 24,890 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2018-02-08 | 2018-02-12 | 69,940 | — | $0 | 69,940 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2017-02-28 | 2017-03-01 | 5,271 | — | $0 | 10,543 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2017-02-28 | 2017-03-01 | 2,678 | — | $0 | 2,679 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2017-02-28 | 2017-03-01 | 2,357 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2017-02-28 | 2017-03-01 | 4,085 | — | $0 | 12,255 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2017-02-28 | 2017-03-01 | 2,678 | — | $0 | 40,235 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2017-02-28 | 2017-03-01 | 5,271 | — | $0 | 45,506 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2017-02-28 | 2017-03-01 | 4,085 | — | $0 | 49,591 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2017-02-28 | 2017-03-01 | 5,361 | $16.45 | $88.2K | 44,230 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2017-02-28 | 2017-03-01 | 2,357 | — | $0 | 37,557 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2017-02-09 | 2017-02-13 | 39,960 | — | $0 | 39,960 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2017-02-09 | 2017-02-13 | 9,990 | — | $0 | 9,990 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2016-02-29 | 2016-03-02 | 2,500 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2016-02-29 | 2016-03-02 | 2,679 | — | $0 | 5,357 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2016-02-29 | 2016-03-02 | 2,357 | — | $0 | 2,357 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2016-02-29 | 2016-03-02 | 5,271 | — | $0 | 15,814 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2016-02-29 | 2016-03-02 | 4,754 | $9.07 | $43.1K | 35,200 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2016-02-29 | 2016-03-02 | 5,271 | — | $0 | 39,954 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2016-02-29 | 2016-03-02 | 2,679 | — | $0 | 34,683 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2016-02-29 | 2016-03-02 | 2,500 | — | $0 | 29,647 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2016-02-29 | 2016-03-02 | 2,357 | — | $0 | 32,004 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2016-02-11 | 2016-02-16 | 16,340 | — | $0 | 16,340 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2016-02-11 | 2016-02-16 | 65,340 | — | $0 | 65,340 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2015-03-02 | 2015-03-03 | 16,250 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2015-03-02 | 2015-03-03 | 18,750 | — | $0 | 56,250 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2015-03-02 | 2015-03-03 | 16,500 | — | $0 | 33,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2015-03-02 | 2015-03-03 | 17,500 | — | $0 | 17,500 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2015-03-02 | 2015-03-03 | 16,250 | — | $0 | 162,600 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2015-03-02 | 2015-03-03 | 16,500 | — | $0 | 196,600 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2015-03-02 | 2015-03-03 | 18,750 | — | $0 | 215,350 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2015-03-02 | 2015-03-03 | 25,318 | $0.94 | $23.8K | 190,032 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2015-03-02 | 2015-03-03 | 17,500 | — | $0 | 180,100 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2015-02-05 | 2015-02-09 | 147,600 | — | $0 | 147,600 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2015-02-05 | 2015-02-09 | 590,400 | — | $0 | 590,400 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2014-02-28 | 2014-03-03 | 17,500 | — | $0 | 35,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2014-02-28 | 2014-03-03 | 16,500 | — | $0 | 49,500 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2014-02-28 | 2014-03-03 | 16,250 | — | $0 | 16,250 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2014-02-28 | 2014-03-03 | 16,500 | — | $0 | 165,018 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2014-02-28 | 2014-03-03 | 16,250 | — | $0 | 131,018 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2014-02-28 | 2014-03-03 | 18,668 | $1.92 | $35.8K | 146,350 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2014-02-28 | 2014-03-03 | 17,500 | — | $0 | 148,518 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2014-02-06 | 2014-02-10 | 300,000 | — | $0 | 300,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2014-02-06 | 2014-02-10 | 75,000 | — | $0 | 75,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2013-02-28 | 2013-03-01 | 17,500 | — | $0 | 52,500 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2013-02-28 | 2013-03-01 | 16,250 | — | $0 | 32,500 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2013-02-28 | 2013-03-01 | 16,250 | — | $0 | 109,840 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2013-02-28 | 2013-03-01 | 12,572 | $1.98 | $24.9K | 114,768 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2013-02-28 | 2013-03-01 | 17,500 | — | $0 | 127,340 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2013-02-08 | 2013-02-12 | 66,000 | — | $0 | 66,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2013-02-08 | 2013-02-12 | 264,000 | — | $0 | 264,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2013-01-31 | 2013-02-04 | 31,600 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2013-01-31 | 2013-02-04 | 12,537 | $2.11 | $26.5K | 93,590 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2013-01-31 | 2013-02-04 | 31,600 | — | $0 | 106,127 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2012-02-28 | 2012-03-01 | 16,250 | — | $0 | 48,750 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2012-02-28 | 2012-03-01 | 5,907 | $1.78 | $10.5K | 58,277 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2012-02-28 | 2012-03-01 | 16,250 | — | $0 | 74,527 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2012-02-15 | 2012-02-17 | 280,000 | — | $0 | 280,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2012-02-15 | 2012-02-17 | 70,000 | — | $0 | 70,000 | SEC↗ |